Market Place
Sourcing Support
Spur Therapeutics Unveils Phase 1/2 Data For Gene Therapy
04 Feb 2026 //
GLOBENEWSWIRE
Spur Therapeutics To Present Gaucher Disease Gene Therapy Data
01 Oct 2025 //
GLOBENEWSWIRE
Spur Therapeutics Presents Positive Data at ASGCT Meeting
15 May 2025 //
GLOBENEWSWIRE
Spur Therapeutics to Present Data at ASGCT Annual Meeting
28 Apr 2025 //
GLOBENEWSWIRE
Spur Presents GALILEO-1 Trial Data for FLT201 in Gaucher Disease
04 Feb 2025 //
GLOBENEWSWIRE
Spur Therapeutics Reports FDA End-of-Phase 2 Meeting for FLT201
03 Feb 2025 //
GLOBENEWSWIRE
Spur Highlights FLT201 Data For Gaucher Disease At WORLDSymposium
23 Jan 2025 //
GLOBENEWSWIRE
Spur Announces Parkinson’s Disease Gene Therapy Candidate
03 Dec 2024 //
GLOBENEWSWIRE
Spur Therapeutics to Join B. Riley Tissue Delivery Summit
07 Nov 2024 //
GLOBENEWSWIRE
Spur Therapeutics Publishes Preclinical Data for SBT101 in AMN
31 Oct 2024 //
GLOBENEWSWIRE
Spur Therapeutics Show Data From Gallileo-1 Trial Annual Congress
23 Oct 2024 //
GLOBENEWSWIRE
Spur To Present FLT201 Gaucher Data At ESGCT 31st Congress
03 Oct 2024 //
GLOBENEWSWIRE
Spur To Join Chardan Genetic Medicines Conference
23 Sep 2024 //
GLOBENEWSWIRE
Spur Therapeutics Announces New Name And Brand
17 Jun 2024 //
GLOBENEWSWIRE
Freeline Positive Gaucher Gene Therapy Data At ASGCT 2024
09 May 2024 //
GLOBENEWSWIRE
Syncona throws lifeline to Freeline by buying struggling biotech
22 Nov 2023 //
FIERCE BIOTECH
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201
25 Oct 2023 //
GLOBENEWSWIRE
Syncona eyes buyout of gene therapy biotech Freeline
18 Oct 2023 //
ENDPTS
Freeline to Present New Data for FLT201 in Gaucher Disease in Presentation
16 Oct 2023 //
GLOBENEWSWIRE
Freeline Reports Positive Data from Phase 1/2 GALILEO-1 Trial of FLT201
04 Oct 2023 //
GLOBENEWSWIRE
Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201
25 Jul 2023 //
GLOBENEWSWIRE
Freeline Announces First Patient Dosed with Gene Therapy Candidate for Gaucher Disease
26 Jun 2023 //
GLOBENEWSWIRE
Freeline Granted ILAP Designation in United Kingdom by MHRA for FLT201
22 May 2023 //
GLOBENEWSWIRE
Freeline cans another 30% of its staff months after last layoffs
05 Apr 2023 //
FIERCE BIOTECH
Forcefield signs exclusive patent and know-how license agreement with Freeline
04 Apr 2023 //
GLOBENEWSWIRE
Freeline Reports Full Year 2022 Financial Results and Provides Corporate Update
04 Apr 2023 //
GLOBENEWSWIRE
Freeline Publishes Preclinical Proof-of-Concept Data for FLT190
19 Jan 2023 //
GLOBENEWSWIRE
